Current Scenario of Cancer- The Incidence of Cancer in Men

Speciality: Oncology


Speaker:

Dr. Ashish Singh | MBBS, MD, Medical Oncology, CMC

Description:

A warm welcome to all the medical professionals in this crucial session on understanding the current scenario of cancer. This presentation will provide a detailed overview of the incidence of cancer in men, focusing on prevalent trends, key risk factors, and the importance of early detection. Globally, cancer is a leading cause of death, and its burden on men varies significantly by region and lifestyle. Understanding the most common cancers that affect men, such as prostate, lung, and colorectal cancer, is essential for developing effective prevention and screening strategies.

The current landscape of cancer in men is characterized by the dominance of a few specific types. In many parts of the world, prostate cancer is the most frequently diagnosed cancer, while lung and bronchus cancer remains the leading cause of cancer-related deaths. Other common malignancies include colorectal cancer, oral cancer, and head and neck cancers, which are often linked to modifiable risk factors like tobacco use and alcohol consumption. A deeper look at the incidence data reveals geographical disparities, with certain regions showing higher rates of specific cancers due to unique environmental, genetic, and lifestyle factors.

Therefore, get an overall knowledge of the current scenario of cancer incidence in men. Listen to the webinar, led by Dr. Ashish Singh, absorb the shared knowledge on the latest trends and diagnostic advancements, and follow Hidoc for more such insightful webinar sessions.


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

2.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

3.

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

4.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

5.

Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot